Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 28, 2022

BUY
$42.05 - $47.77 $6,307 - $7,165
150 Added 0.62%
24,477 $1.07 Million
Q1 2022

Apr 19, 2022

BUY
$40.23 - $47.74 $897,692 - $1.07 Million
22,314 Added 1108.49%
24,327 $1.06 Million
Q4 2021

Jan 14, 2022

SELL
$38.88 - $45.31 $11,858 - $13,819
-305 Reduced 13.16%
2,013 $89,000
Q3 2021

Oct 21, 2021

BUY
$38.79 - $43.16 $26,377 - $29,348
680 Added 41.51%
2,318 $89,000
Q2 2020

Jul 21, 2020

SELL
$37.87 - $43.58 $7,573 - $8,716
-200 Reduced 10.88%
1,638 $67,000
Q1 2020

Apr 16, 2020

BUY
$32.47 - $48.83 $6,494 - $9,766
200 Added 12.21%
1,838 $70,000
Q4 2018

Jan 24, 2019

SELL
$37.8 - $42.69 $2,532 - $2,860
-67 Reduced 3.93%
1,638 $63,000
Q3 2018

Oct 30, 2018

BUY
$39.75 - $42.69 $2,663 - $2,860
67 Added 4.09%
1,705 $68,000
Q4 2017

Jan 26, 2018

SELL
$35.34 - $41.9 $8,022 - $9,511
-227 Reduced 12.17%
1,638 $58,000
Q3 2017

Oct 19, 2017

BUY
$39.44 - $41.55 $73,555 - $77,490
1,865
1,865 $76,000

Others Institutions Holding GSK

About GSK PLC


  • Ticker GSK
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,033,689,984
  • Market Cap $67.3B
  • Description
  • GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...
More about GSK
Track This Portfolio

Track Farmers & Merchants Investments Inc Portfolio

Follow Farmers & Merchants Investments Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Farmers & Merchants Investments Inc, based on Form 13F filings with the SEC.

News

Stay updated on Farmers & Merchants Investments Inc with notifications on news.